ADALIMUMAB SERUM DRUG LEVELS AND ANTI-DRUG ANTIBODIES: ASSOCIATION TO DISEASE ACTIVITY AND DRUG SURVIVAL IN INFLAMMATORY ARTHRITIS PATIENTS

被引：0
|
作者：
Jyssum, I. [1 ,2 ]
Gehin, J. E. [3 ]
Kristianslund, E. [1 ]
Sexton, J. [1 ]
Worren, D. [3 ]
Hu, Y. [4 ]
Kvien, T. K. [1 ]
Haavardsholm, E. A. [1 ,2 ]
Bolstad, N. [3 ]
Syversen, S. W. [1 ]
Goll, G. L. [1 ]
机构：
[1] Diakonhjemmet Hosp, Ctr treatment Rheumat & Musculoskeletal Dis REMED, Oslo, Norway
[2] Univ Oslo, Inst Clin Med, Oslo, Norway
[3] Norwegian Radium Hosp, Dept Med Biochem, Oslo, Norway
[4] Lillehammer Hosp, Dept Rheumatol, Lillehammer, Norway
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Inflammatory arthritides; bDMARD;
D O I：
10.1136/annrheumdis-2023-eular.1369
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0345
引用
收藏
页码：421 / 422
页数：2
相关论文
共 50 条
  • [41] Anti-drug antibodies to infliximab: A comparison of free anti-drug antibody measurement
    Hamilton, R.
    Shields, S.
    MacDonald, J.
    Dunlop, A.
    Perry, M.
    McGucken, A.
    Gribben, E.
    Galloway, P.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S249 - S250
  • [42] Adalimumab/methotrexateLack of efficacy and development of anti-drug antibodies : case report
    Reactions Weekly, 2018, 1724 (1) : 18 - 18
  • [43] ANTI-DRUG ANTIBODIES TO INFLIXIMAB: A COMPARISON OF FREE ANTI-DRUG ANTIBODY MEASUREMENT
    Hamilton, Rhona
    Shields, Stephanie
    Macdonald, Jonathan
    Dunlop, Allan
    Perry, Martin
    McGucken, Andrew
    Gribben, Elain
    Galloway, Peter
    GUT, 2021, 70 : A121 - A121
  • [44] Adalimumab/etanerceptNeutralising anti-drug antibodies and lack of efficacy: case report
    Reactions Weekly, 2021, 1844 (1) : 19 - 19
  • [45] Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial
    Uhrenholt, Line
    Sorensen, Mads E. R.
    Lauridsen, Karen B.
    Duch, Kirsten
    Dreyer, Lene
    Christensen, Robin
    Hauge, Ellen-Margrethe
    Loft, Anne Gitte
    Rasch, Mads N. B.
    Horn, Hans Christian
    Taylor, Peter C.
    Nielsen, Kaspar R.
    Kristensen, Salome
    RHEUMATOLOGY INTERNATIONAL, 2024, : 1897 - 1908
  • [46] Utility of Measuring Serum Concentrations of Anti-TNF Agents and Anti-Drug Antibodies in Inflammatory Bowel Disease
    Guerra, Ivan
    Chaparro, Maria
    Bermejo, Fernando
    Gisbert, Javier P.
    CURRENT DRUG METABOLISM, 2011, 12 (06) : 594 - 598
  • [47] CLINICAL IMPORTANCE OF ANTI-DRUG AND SERUM DRUG LEVEL TESTING IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ETANERCEPT
    Drynda, S.
    Kekow, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 499 - 500
  • [48] THE ASSOCIATION BETWEEN 6-THIOGUANINE NUCLEOTIDE LEVELS, ADALIMUMAB DRUG CONCENTRATIONS, ANTI-ADALIMUMAB ANTIBODIES AND DRUG CLEARANCE
    Yarur, Andres
    Abraham, Bincy P.
    Conklin, John
    Everts-van der Wind, Annelie
    Hanauer, Stephen B.
    Dervieux, Thierry
    GASTROENTEROLOGY, 2024, 166 (05) : S829 - S829
  • [49] Positivity thresholds of total infliximab and adalimumab anti-drug antibody assay: The prevalence of clearing and transient anti-drug antibodies in a national therapeutic drug monitoring service
    Nice, R.
    Chanchlani, N.
    Green, H.
    Bewshea, C.
    Kennedy, N.
    Ahmad, T.
    Goodhand, J.
    McDonald, T.
    Perry, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S018 - S019
  • [50] Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease
    Battat, Robert
    Lukin, Dana
    Scherl, Ellen J.
    Pola, Suresh
    Kumar, Anand
    Okada, Lauren
    Yang, Lei
    Jain, Anjali
    Siegel, Corey A.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (09) : 1443 - 1451
12345